methods for reducing weight gain or inducing weight loss, and for treating hyperglycemia, reducing blood glucose levels, or normalizing blood glucose levels.
Methods are provided for administering an extended half-life GLP-1/GIP coagonist peptide to a patient in need thereof for reducing weight gain, inducing weight loss, treating hyperglycemia, reducing blood glucose levels, or normalizing blood glucose levels in said patient.